A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial

Catheterization and Cardiovascular Interventions

Volumn 86, Issue 1, 2015, Pages 164-170

  Rocha Singh, Krishna J ^a   Bosiers, Marc ^b   Schultz, Greg ^c   Jaff, Michael R ^d   Mehta, Manish ^e   Matsumura, Jon S ^f  

^a ST JOHN'S HOSPITAL   (United States)

^b AZ Sint Blasius   (Belgium)

^c SANFORD RESEARCH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e School of Medicine and Public Health ^*  (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

claudication; peripheral arterial disease; stents

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CLAUDICATION; CLINICAL TRIAL (TOPIC); CLINICALLY DRIVEN TARGET LESION REVASCULARIZATION; DEVICE SAFETY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS ASSESSMENT; HUMAN; LEG REVASCULARIZATION; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; SELF EXPANDING STENT; STENT FRACTURE; SUPERFICIAL FEMORAL ARTERY; VASCULAR PATENCY; WALKING IMPAIRMENT SCORE; BLOOD VESSEL TRANSPLANTATION; DUPLEX DOPPLER ULTRASONOGRAPHY; INTERMITTENT CLAUDICATION; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS DESIGN; STENT; TREATMENT OUTCOME;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT CLAUDICATION; MALE; POPLITEAL ARTERY; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 84931957655     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25895     Document Type: Article

References (19)

1. Mwipatayi BP, Leong BD, Hockley J, Vijayan V,. The pitfalls of femoropopliteal stenting trials. J Endovasc Ther 2012; 19: 596-598.
2. Schillinger M, Sabeti S, Loewe C, et al., Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888.
3. Laird JR, Katzen BT, Scheinert D, et al., Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-276.
4. Krankenberg H, Schluter M, Steinkamp HJ, et al., Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292.
5. Dick P, Wallner H, Sabeti S, et al., Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009; 74: 1090-1095.
6. Dearing DD, Patel KR, Compoginis JM, Kamel MA, Weaver FA, Katz SG,. Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg 2009; 50: 542-547.
7. Dake MD, Scheinert D, Tepe G, et al., Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: Twelve-month safety and effectiveness results from the zilver PTX single-arm clinical study. J Endovasc Ther 2011; 18: 613-623.
8. Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M,. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg 2010; 52: 608-615.
9. Scheinert D, Scheinert S, Sax J, et al., Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-315.
10. Schlager O, Dick P, Sabeti S, et al., Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 2005; 12: 676-684.
11. Suzuki K, Iida O, Soga Y, et al., Long-term results of the S.M.A.R.T. control(TM) stent for superficial femoral artery lesions, J-SMART registry. Circ J 2011; 75: 939-944.
12. Bosiers M, Torsello G, Gissler HM, et al., Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther 2009; 16: 261-269.
13. Laird JR, Katzen BT, Scheinert D, et al., Nitinol stent implantation vs. Balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: Three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012; 19: 1-9.
14. Matsumura JS, Yamanouchi D, Goldstein JA, et al., The United States study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the protege everflex nitinol stent system II (DURABILITY II). J Vasc Surg 2013; 58: 73-83 e1.
15. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM,. Investigators V. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 2013; 58: 386-395 e4.
16. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G,. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 2007; 69: 910-919.
17. Kawarada O, Higashimori A, Noguchi M, et al., Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv 2013; 81: E199-205.
18. Higashimori A, Kawarada O, Morioka N, et al., Impact of changing PSVR thresholds on the patency rates of SFA recanalisation with self-expanding nitinol stents. EuroIntervention 2013; 9: 964-967.
19. Dake MD, Ansel GM, Jaff MR, et al., Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: Twelve-month zilver PTX randomized study results. Circ Cardiovasc Interv 2011; 4: 495-504.